Baird Medical Investment Holdings Ltd (BDMD) stock
BDMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BDMDW
$0.11+0.00 (+3.17%)
Close on Nov 12, 2026Market cap $4.40MP/E –Yield –
Baird Medical Investment statistics
83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.13
- 4.85
Enterprise valuationIndustry
- EV / Sales
- 0.52
- 2.70
Share statisticsIndustry
- Shares Change (YoY)
- 27.3%
- 3.22%
- Float
- 16M
- 37M
- Shares Held by Insiders
- 62.0%
- 10.5%
Short sellingIndustry
- Short Interest
- 217,561
- –
- Short Interest Change
- 858.6%
- -2.57%
- Days to Cover
- 1.00
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $3.70
- –
- 52-Week Low
- $0.07
- –
- 20-Day Moving Average
- $0.26
- –
- 50-Day Moving Average
- $0.63
- –
- 200-Day Moving Average
- $1.29
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- -31.9%
- 2.01%
- Price Change (1 Month)
- -80.5%
- -0.57%
- Price Change (3 Months)
- -90.5%
- -7.91%
- Price Change (6 Months)
- -93.7%
- -0.90%
- Price Change (YTD)
- -92.1%
- -0.82%
- Price Change (1 Year)
- -91.3%
- -1.18%
- Price Change (3 Years)
- -99.0%
- 6.56%
- Average Volume (10 Days)
- 98M
- –
- Average Volume (20 Days)
- 49M
- –
- Average Volume (90 Days)
- 11M
- –
- Relative Volume
- 10.33
- 0.82
- Relative Strength Index (14)
- 22.8
- 47.7
- Volatility (1 Year)
- 147.6%
- 64.2%
- Beta (5 Years)
- -0.03
- 1.05
MarginsIndustry
- Pretax Margin
- -117.0%
- -2.55%
- EBITDA Margin
- -108.8%
- -2.82%
- FCF Margin
- -6.15%
- 0.40%
Returns on capitalIndustry
- Return on Equity (ROE)
- -77.5%
- -17.1%
- Return on Assets (ROA)
- -36.2%
- -12.2%
- Return on Invested Capital (ROIC)
- -48.2%
- -3.22%
- Return on Capital Employed (ROCE)
- -65.8%
- -8.13%
Financial positionIndustry
- Current Ratio
- 1.29
- 2.45
- Quick Ratio
- 0.88
- 1.53
- Debt / Equity
- 0.22
- 0.42
- Interest Coverage
- -72.33
- -1.68
GrowthIndustry
- Revenue Growth (YoY)
- -39.2%
- 9.24%
- Net Income Growth (YoY)
- -319.0%
- 13.4%
- EPS Growth (YoY)
- -271.9%
- 15.1%
- Revenue Growth (3Y CAGR)
- -13.7%
- 7.08%
EfficiencyIndustry
- Asset Turnover
- 0.30
- 0.59
- Inventory Turnover
- 2.97
- 2.20
- Revenue Per Employee
- $154.36K
- $330.60K
- Profits Per Employee
- -$186.84K
- -$41.39K
- Employee Count
- 146
- 186
- WACC
- 5.15%
- 9.71%
Income statement (TTM)Industry
- Pretax Income
- -$26.38M
- -$1.69M
Balance sheetIndustry
- Net Cash (Debt)
- -$7.46M
- $3.73M
- Net Cash Per Share
- -$0.18
- $0.24
- Equity (Book Value)
- $34.78M
- $63.44M
- Book Value Per Share
- $0.85
- $3.26
- Tangible Book Value
- $34.71M
- $11.04M
- Working Capital
- $10.18M
- $56.85M
Cash flow (TTM)Industry
- Capital Expenditures
- -$42.32K
- -$3.69M
- FCF Per Share
- -$0.03
- -$0.01
Dividends and yieldsIndustry
- Earnings Yield
- -620.4%
- -4.70%
- FCF Yield
- -31.5%
- 0.24%
Taxes and interestIndustry
- Interest Expense
- $354.34K
- $5.33M
- Income Tax
- $1.17M
- $1.63M
Scores and fair valueIndustry
- Altman Z-Score
- -0.62
- 2.44
- Piotroski F-Score
- 1
- 5
- Beneish M-Score
- -4.60
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BDMD | S&P 500 | Difference | BDMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -85.7% | -2.7% | −83.0 pts | ||
| 3 months | -90.9% | -1.7% | −89.2 pts | ||
| Year to date | -92.1% | +11.9% | −104.0 pts | ||
| 1 year | -91.7% | +12.0% | −103.7 pts | ||
| 3 years | -99.0% | +78.2% | −177.2 pts | -78.4% | +21.2% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M BDMD shares were sold short on Oct 30, 2026, up 858.6% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 52.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 217,561 | +858.6% | 1,165,388 | 1.0 |
| Oct 15, 2026 | 22,695 | -15.6% | 63,042 | 1.0 |
| Sep 30, 2026 | 26,899 | +5.6% | 84,336 | 1.0 |
| Sep 15, 2026 | 25,463 | -26.4% | 38,621 | 1.0 |
| Aug 31, 2026 | 34,603 | +42.3% | 35,779 | 1.0 |
| Aug 14, 2026 | 24,316 | +20.9% | 64,462 | 1.0 |
| Jul 31, 2026 | 20,109 | +1.6% | 37,742 | 1.0 |
| Jul 15, 2026 | 19,796 | -40.4% | 68,010 | 1.0 |
| Jun 30, 2026 | 33,197 | -39.8% | 171,545 | 1.0 |
| Jun 15, 2026 | 55,105 | -40.8% | 104,817 | 1.0 |
| May 29, 2026 | 93,029 | -22.4% | 114,242 | 1.0 |
| May 15, 2026 | 119,902 | -45.2% | 219,779 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?